We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Access Consortium — comprising regulatory authorities from the UK, Australia, Canada, Singapore and Switzerland — works together to streamline regulatory processes, support innovation and improve global public health out…
Nearly 20 million doses of potentially dangerous medicines prevented from reaching the public
People living in rural and coastal areas will find it easier to see a cancer specialist as the government works to end the postcode lottery for care.
The updated safety measures will strengthen the MHRA’s ability to monitor safe prescribing while supporting patient access to treatment across all age groups.
Study confirms vaccine being used in global efforts to achieve and sustain polio eradication is successfully interrupting polio outbreaks whilst minimising risk of new vaccine-derived outbreaks in Uganda
Paracetamol should be taken as directed in the patient information leaflet.
Government rolling out Jess's Rule posters to all GP surgeries in England to act as reminder of a life-saving patient safety initiative.
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.
Infected Blood Compensation Authority's update that was circulated on 15 January 2026
Waiting lists in 20 areas in England fall 3 times faster than the national average thanks to experts deployed by government to help supercharge NHS care.
The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting the UK’s competitiveness for global clinical research.
Wes Streeting, Secretary of State for Health and Social Care, delivers a keynote speech on NHS reform at the Institute for Government's annual conference.
Healthcare industry innovator Dr Melanie Ivarsson has been appointed as CEO of the Health Data Research Service (HDRS) to accelerate medical breakthroughs.
Updated product information and packaging will help patients better understand the risks of dependency, addiction, and withdrawal with these medicines.
As medicines and medical technologies become more complex, there are exciting opportunities to further strengthen our safety monitoring systems.
As with any medicine, the MHRA will keep the safety and effectiveness of Nirogacestat hydrobromide under close review.
In this new role, Professor George will lead the Agency’s science strategy and will oversee the MHRA’s scientific, research and innovation activities.
Children will be protected from exposure to junk food ads under new regulations, in a bid to tackle childhood obesity.
As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review.
A new £2 million pilot will see health visitors reach families facing barriers to vaccines, to ensure more children are protected.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).